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ARTICLE OPEN
Systematic review of the effectiveness of community-based self-
management interventions among primary care COPD
patients
K. Jolly 1, M. S. Sidhu2, E. Bates1, S. Majothi1, A. Sitch1, S. Bayliss1, H. J. Samuel Kim3 and R. E. Jordan1
COPD self-management reduces hospital admissions and improves health-related quality of life (HRQoL). However, whilst most
patients are managed in primary care, the majority of self-management trials have recruited participants with more severe disease
from secondary care. We report the ﬁndings of a systematic review of the effectiveness of community-based self-management
interventions in primary care patients with COPD. We systematically searched eleven electronic databases and identiﬁed 12 eligible
randomised controlled trials with seven included in meta-analyses for HRQoL, anxiety and depression. We report no difference in
HRQoL at ﬁnal follow-up (St George’s Respiratory Questionnaire total score −0.29; 95%CI −2.09, 1.51; I2 0%), nor any difference in
anxiety or depression. In conclusion, supported self-management interventions delivered in the community to patients from
primary care do not appear to be effective. Further research is recommended to identify effective self-management interventions
suitable for primary care populations, particularly those with milder disease.
npj Primary Care Respiratory Medicine           (2018) 28:44 ; doi:10.1038/s41533-018-0111-9
INTRODUCTION
COPD is a signiﬁcant cause of morbidity and mortality; it accounts
for a high consultation rate in general practice1 as well as
signiﬁcant hospital admission rates for exacerbations which drive
the high cost of treatment.2 Support for self-management among
people with COPD has been shown by systematic reviews to
improve health-related quality of life (HRQoL) and reduce hospital
admissions.3 However, most participants within self-management
trials have been recruited from secondary care with more severe
disease than is representative of the population of patients with
COPD seen in general practice.4,5 In the UK and increasingly in
many other countries, most people with COPD are managed in
primary care. Deﬁciencies in self-management support have been
identiﬁed in patients attending UK primary care with suboptimal
rates of patients having a self-management plan, having received
advice on diet or exercise or practical help to stop smoking in the
previous year.6 Interventions to support self-management are
heterogeneous and there is a lack of evidence as to whether
effective interventions can be implemented and delivered in
primary care settings. This is of increasing importance with calls to
intervene to reduce risk in people with early stage COPD.7
There is a need for a systematic review to collate the evidence
of the effectiveness of interventions to support self-management
of patients with COPD identiﬁed from primary care with the
intervention delivered in primary care or within a community
setting. The aim of this review is to evaluate whether self-
management interventions in COPD patients recruited from
primary care lead to improved health-related quality of life,
improved health outcomes and reduced health care utilisation.
RESULTS
Study selection
The search results for the systematic review are shown in the
PRISMA ﬂow diagram (Fig. 1). The original search of databases
from inception to 2012 identiﬁed 11,046 abstracts after removal of
duplicates,7 from which eight full text articles were assessed. The
updated search, focussed on primary care, identiﬁed 1255
abstracts from which 72 full text articles were assessed for
eligibility; in total 12 articles met the full eligibility criteria. As
outcome measures were heterogeneous between studies, only
seven studies shared outcome measures which allowed inclusion
in the meta-analyses.
Overall study characteristics
Study characteristics of included studies are presented in Table 1
(for full details see Supplementary Table 1). Seven trials were
individually randomised and 5 trials were cluster RCTs.8–12 Four
trials were carried out in the UK, two in Australia and one each in
The Netherlands, Sweden, Germany, US, China and New Zealand.
Apart from one three-arm trial,13 all were two arm trials. Trials
ranged from 5214 to 82179 participants, including a total of 10,647
patients. The control arm of studies was most frequently usual
care, with two studies providing information booklets as part of
the control arm15,16 and one using usual care with an assessment
of the patients’ health status every 2 months9. One study provided
non-interventional brief telephone calls to usual care participants
to control for the effect of the additional attention received by the
intervention group.11 Duration of follow-up ranged from
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3 months17 to 4 years.9 All participants were recruited from
disease registers within general practices or community centres.
Participant characteristics
The mean age of participants ranged from 61 to 73 years and
48.1% of the participants were male. Where reported, mean forced
expiratory volume in one second (FEV1) ranged from 5110 to
66%13 of predicted values in the intervention arms at baseline.
Apart from one study,12 the eligibility criteria of the studies was an
FEV1/FVC < 0.7; other criteria included FEV1 < 80% pre-
dicted,11,16,18 MRC 3 or more,15 MRC 2 or more19 and at high
risk of hospital admission.8
Intervention characteristics
Interventions were heterogeneous and duration ranged from one
month15 to at least 2 years.9 Interventions were delivered by a
variety of health care professionals (GPs, nurse practitioners,
medical assistants, respiratory physician nurses, health psycholo-
gists and trained peers); several studies used combinations of
health professionals to deliver the intervention. Some studies used
experienced health care professionals who were not speciﬁcally
trained to deliver the intervention,10,14,17,19 in two studies the
training was not speciﬁed,13,18 whilst most training of health care
professionals ranged from 8 hours16 to 2 days.8,9,12 The content of
the interventions varied from being focussed mainly on exacer-
bation management and responding to participants self-
management queries17 to very comprehensive programmes
including information about educational materials, physical
activity advice, smoking cessation, breathing and medication
management.9,14,19
Outcome measures
Health-related quality of life (HRQoL) was reported by 10 studies,
but only the St George’s Respiratory Questionnaire (SGRQ) and
Chronic Respiratory Disease Questionnaire (CRQ) were included in
more than one study allowing meta-analysis of these measures.
Five studies included the SGRQ,11,12,14,16,18 but this was reported
variably. Three studies included CRQ, reporting domains of
dyspnea, emotions, fatigue and mastery.13,15,19 One study
reported the CAT.17 Other measures included the Hospital Anxiety
and Depression Scale (HADS),9,11,15,18,19 EQ-5D, exercise capacity,
lung function, dyspnea and health care utilisation.
Quality appraisal and risk of bias of included studies
Figure 2 summarises the methodological quality and risk of bias
for included studies, full details are given in Supplementary Table
2. Nine trials explicitly stated the process of randomisation. Details
of allocation concealment and/or blinding were either poorly
described or not provided. Four studies provided a complete
description of drop outs and withdrawals, with signiﬁcant
information about the reasons for why participants dropped out
or were lost to follow-up. However, four studies did not report an
intention to treat analysis, 9,11,16,18 one had a baseline imbalance
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in lung function that was not adjusted for in the analysis,12 and
one study did not report the method of randomisation.14
Effectiveness results
In the meta-analyses, there was no difference in HRQoL measured
by the SGRQ at ﬁnal follow-up (SGRQ total score −0.29, 95%CI
−2.09, 1.51; I2 0%) (Fig. 3), nor any signiﬁcant differences in the
SGRQ domains (Table 2 and supplementary ﬁgures 1-3). The SGRQ
activity (mean difference −1.56, 95%CI −4.22, 1.10; I2 0%),
symptoms (mean difference −1.47, 95%CI −4.74, 1.80; I2 0%)
and impacts scores (mean difference −0.63, 95%CI −2.65, 1.38; I2
0%) were in the direction favouring the self-management
interventions, but did not reach statistical signiﬁcance. No trials
in the meta-analyses reported a statistically signiﬁcant ﬁnding for
the SGRQ total or any of its domains. Three of the trials in the
meta-analysis did not report intention to treat analyses11,16,18 and
one had baseline imbalance in lung function.12
The meta-analysis results for the CRQ domains of dyspnea,
emotions, fatigue and mastery were in the direction favouring the
self-management interventions, but none reached statistical
signiﬁcance and there were high levels of heterogeneity (Table
2 and supplementary ﬁgures 4-7). Howard et al., reported
statistically signiﬁcant differences between intervention and
control for all four CRQ domains for an intervention that used
cognitive behavioural therapeutic approach to address dyspnea.15
Of the trials that were not included in the meta-analyses,
Billington et al.17, which had a low risk of bias, reported a
signiﬁcant and clinically important difference20 between the COPD
Assessment Test (CAT) scores of the intervention and control
groups at 3 months after adjusting for baseline CAT scores (mean
difference 2.38, 95% CI 4.40, 0.36; p= 0.02), but this did not remain
signiﬁcant after adjusting for age, smoking and FEV1% predicted
at baseline. In contrast, Effraimsson et al. reported statistically
signiﬁcant differences in the change from baseline to follow-up at
5 months in the SGRQ domains of symptoms, activity and impacts
between the intervention and usual care groups favouring self-
management.14 Rea, for which risk of bias assessment was largely
unclear, reported signiﬁcantly greater improvements on the CRQ
domains of fatigue and mastery compared to usual care, but no
difference for dyspnea or emotional functions.10
For generic quality of life, Freund et al. reported signiﬁcant
improvement in quality of life (SF-12) in the intervention group
compared with the usual care group at 24 months (differences
1.16, 95% CI 0.24, 2.08) on the physical component and 1.68 (95%
CI 0.60, 2.77) on the mental component).8 General health
(difference on EQ-5D 0.03, 95% CI, 0.00, 0.05) was also signiﬁcantly
improved at 24 months.8 In both trials reporting the SF-36, there
were no differences for any of the SF-36 domains between
intervention and control.11,16
In the meta-analyses, HADS anxiety and depression were not
signiﬁcantly different between intervention and controls; hetero-
geneity was substantial for the depression analysis and two of the
included trials were at high risk of bias due to lack of use of
intention to treat analysis.11,18 However, in Lou et al., which also
did not undertake intention to treat analysis, signiﬁcantly lower
proportions of intervention participants had a score of 8 or more
(indicating possible anxiety or depression) on the HADS anxiety
and depression scales at 4 years follow-up.9
Seven of the trials reported health care utilisation outcomes
with most reporting no statistically signiﬁcant differences at
follow-up in ED visits12,15,16 and hospital admissions.8,10,12,16
Billington et al. had too few emergency department (ED) visits
to make a comparison;17 Freund, Coultas, Zwar, Howard and Rea
et al. did not show statistically signiﬁcant differences at follow-up
in ED visits12,15,16 and hospital admissions.8,10,12,16 At 4 years
follow-up, Lou et al. reported 16.1% (95% CI 9.3, 23.2) fewer all-
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cause hospital admissions and 18.1% (95% CI 10.2, 27.9) lower ED
visits in the intervention compared to the usual care group.9
Distance walked in the 6-minute walk test was statistically
signiﬁcantly greater in the intervention than usual care group
(43m; 95%CI 12, 75) in Lou et al. at 4 years follow-up.9 Mitchell
et al. reported a signiﬁcant difference in duration of the endurance
shuttle walk test at 6 weeks, sustained to 6 months; but the
incremental shuttle walk distance did not reach the minimally
important difference within the intervention group or between
groups.19
Only two trials reported lung function.9,12 At 4 years follow-up
there was a signiﬁcant difference in lung function between the
intervention and usual care groups in Lou et al., with the self-
management group having a smaller reduction in FEV1%
predicted.9 Zwar et al. reported no difference in FEV1% predicted
between groups at 12 months follow-up.12
In Lou et al., after 4 years, the mean MMRC dyspnoea score in
the self-management group decreased by a mean of 0.4 (SD 0.3),
whereas in the control group, this score increased by 0.3 (SD 0.2);
difference between the 2 groups p < 0.001.9
Only Bischoff reported exacerbations. Frequency of exacerba-
tions did not differ between the groups, but compared with usual
care, more exacerbations in the self-management group were
managed with prednisolone, antibiotics, or both (difference 3.98,
95% CI 1.10, 15.58).13
Two trials reported mortality, Freund reported no difference,
whereas Lou reported a signiﬁcantly lower mortality rate in the SM
group at 4 years follow-up (difference 9.0%, 95% CI 5.6, 12.7; p <
0.001).9
DISCUSSION
Despite extensive searches, we identiﬁed only 12 RCTs. In contrast
to studies among more severe COPD patients, community-based
interventions to support self-management for COPD in primary
care were not found to be effective in meta-analyses overall in
improving health-related quality of life or in reducing anxiety and
depression. Although effects favoured the intervention groups,
they were not statistically signiﬁcant. However, despite the lack of
statistical signiﬁcance, the differences seen on the CRQ dyspnea,
emotions and mastery scores were consistent with the minimally
clinically important difference of 0.5, but this was driven largely by
one trial which focused on dyspnea management.15 The hetero-
geneity of outcome measures precluded synthesis of the full
evidence. In contrast to most of the other studies, one large trial
undertaken in China,9 which could not be included in the meta-
analyses, reported clinically and statistically signiﬁcant improve-
ments in mortality, HRQoL, anxiety and depression, dyspnea,
exercise capacity, lung function and hospital ED visits and hospital
admissions. The patient population was similar to that of the other
included trials. The intervention was very intensive, involving
education sessions every 2 weeks for 2 years, thus unlikely to be
reproduced in other primary care settings; the intervention also
included secondary care specialists reviewing the patients in the
primary care setting every 2 months, and the usual care may well
have been less comprehensive than that provided in some other
countries, with participants having low levels of COPD medica-
tions and a high mortality in the usual care group.9 Additionally,
the trial had differential follow-up between the intervention and
control groups (81.4 vs 69.7%) and no intention to treat analysis.
Another large trial not included in the meta-analyses, but
generally well conducted, Freund et al.,8 reported positive effects
on HRQoL, but no effect on health care utilisation. This included
patients with type II diabetes and heart failure as well as COPD
and thus reported few characteristics speciﬁc to the COPD
participants, so it is difﬁcult to compare the participants to those
of the other included trials. This intervention was also intensive,
with a mean of 11 contacts, and included intervention compo-
nents that were tailored to the individual patient through
collaborative goal setting.
The ﬁndings of this review differ from those reported in the
2014 Cochrane review which reported a signiﬁcant improvement
in HRQoL in patients allocated to self-management support for
COPD (SGRQ total 3.51, 95% CI 1.65, 5.37) and reduction in
respiratory admissions (OR 0.57, 95% CI 0.43, 0.75) compared to
usual care.3 The trials in the Cochrane review mainly recruited
participants from secondary care settings, some of which only
included participants with GOLD 3 or 4 or who had a recent
hospital admission, and thus on average, the participants of the
included trials had more severe disease than in our review. In line
with other systematic reviews of self-management support in a
range of settings, we did not ﬁnd signiﬁcant differences in anxiety
or depression.3,21 An RCT published since our searches were
undertaken, reported the ﬁndings of a telephone health coaching
self-management intervention in a UK primary care population
with only mildly symptomatic COPD.22 In keeping with the
ﬁndings of our systematic review this trial also reported no
difference between study groups for the SGRQ-total score (mean
difference −1.3, 95%CI −3.6 to 0.9) or HADS at 12 months follow-
up.22
We did not plan sub-group analyses to explore the effects of
individual components of the self-management interventions.
However, we note that only four of the interventions in our review
included action plans as a component.8,13,17,19 This contrasts to
the ﬁndings of the Cochrane systematic review 3 where sub-
analyses on the use of action plans could not be performed
because almost all the studies included COPD exacerbation action
plans.
Whilst the number of published RCTs of COPD self-
management support in primary care is limited there have been
Table 2. Effect of self-management interventions on outcomes: meta-analyses
Outcome No. of studies Studies No. of participants Summary mean difference (95% CIs) I2 (%)
SGRQ-total 4 Coultas; Taylor; Walters; Zwar 851 −0.29 (−2.09, 1.51) 0.0
SGRQ-impacts 3 Coultas; Taylor; Walters 400 −0.63 (−2.65, 1.38) 0.0
SGRQ-symptoms 3 Coultas; Taylor; Walters 400 −1.47 (−4.74, 1.80) 0.0
SGRQ-activity 3 Coultas; Taylor; Walters 400 −1.56 (−4.22, 1.10) 0.0
CRQ-dyspnea 3 Bischoff; Howard; Mitchell 516 0.76 (−0.24, 1.76) 90.9
CRQ-emotions 3 Bischoff; Howard; Mitchell 516 0.85 (−0.20, 1.90) 93.5
CRQ-fatigue 3 Bischoff; Howard; Mitchell 516 0.45 (−0.26, 1.16) 83.3
CRQ-mastery 3 Bischoff; Howard; Mitchell 516 0.57 (−0.24, 1.38) 89.5
HADS anxiety 4 Howard; Mitchell; Taylor; Walters 676 −0.35 (−0.91, 0.21) 37.1
HADS depression 4 Howard; Mitchell; Taylor; Walters 676 −0.59 (−1.51, 0.33) 82.0
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a range of other primary care based trials addressing the self-
management support and care of patients with COPD alongside
other long term conditions. Kennedy et al. trained practice staff
taking a systems level approach, reporting no improvement in
HRQoL;23 Cartwright24 and Steventon25 evaluated a telehealth
intervention reporting a reduction in hospital admissions and on
mortality, but also no effect on quality of life.
A recent qualitative systematic review of barriers and facilitators
to self-management of COPD may offer potential explanations as
to the lack of effect of the primary care COPD self-management
interventions.26 This highlighted the importance of the emotional
and psychological burden of COPD.26 This is supported by
evidence that interventions that address mental health have
been shown to be more effective than those focussing only on
symptom management.3,27 Whilst some of the trials included in
our review included the management of stress or anxiety, this was
not universal. In addition, qualitative research with health care
professionals who provide self-management support has identi-
ﬁed the role of life circumstances impacting on people’s ability to
engage in self-management.28 Practitioners’ speciality, experience
and interest in COPD inﬂuences how COPD self-management is
supported,28 which might account for smaller effects in COPD self-
management delivered by primary care teams compared to
specialists. In addition, the interventions targeted different self-
management behaviours, thus some interventions might be
expected to impact some of the outcomes more than others.
Whilst only three of the trials overtly addressed anxiety and
depression through relaxation and psychological interven-
tions,9,13,15 most other trials included disease education, breathing
management and exercise, which all try to address the cycle of
activity leading to breathlessness which leads to anxiety. HRQoL is
a broad concept, encompassing the impact of COPD on activities,
psychological health and social functioning. The trial interventions
addressed elements of different components of HRQoL and as 10
of the 12 included trials included HRQoL as an outcome measure,
usually using a disease speciﬁc HRQoL measure, the authors
clearly considered that the intervention components had the
potential to impact HRQoL.
Our review has several strengths and some limitations. We
completed an extensive review of published and grey literature
and included evidence from 12 RCTs, although only seven
contributed to the meta-analyses. The primary outcome of our
review is HRQoL. Whilst this has been shown to be sensitive to
self-management interventions in patients with more severe
disease recruited from secondary care settings,3 or after hospital
admission, it may be less sensitive to change in people with less
severe symptoms managed in primary care. In addition, as people
adapt to their disease their perception of their HRQoL may
change. Our search strategy was comprehensive. However, RCTs
varied considerably in sample size and nature of interventions. A
wide range of different outcomes was reported and only one
study reported exacerbations. Although we were able to make
some comparisons across studies, there may be sources of
heterogeneity where there are differences in study design or
population characteristics. Further, there was missing information
in the reporting of study methods and results which limit the
application of our ﬁndings. Some trials reported a high loss to
follow-up,15 imbalance in baseline characteristics,12,14,18 or base-
line characteristics on only those who were followed-up.16 Five of
the trials were cluster design, but none reported an intra-cluster
correlation coefﬁcient, so we were unable to adjust for clustering
in the meta-analyses. Few studies reported the ﬁdelity of delivery
of the intervention, so descriptions of the intervention are those
planned, rather than those received.
With the limited number of trials reporting each outcome
measure it was not possible to assess publication bias.
A considerable challenge of undertaking evidence syntheses in
COPD is the range of outcome measures commonly used,
measuring different domains and therefore precluding synthesis
by meta-analysis. This limits the numbers of participants in each
analysis. Additionally, a lack of standardisation in relation to
reporting health care utilisation and exacerbations limits compar-
ison between studies. Future consensus among the respiratory
research community on a standard reporting framework would be
beneﬁcial.
The heterogeneity of the different populations and interven-
tions are a challenge to interpreting the ﬁndings in relation to the
features of self-management interventions in primary care. A
recent individual patient data (IPD) meta-analysis reported that
self-management for COPD was more effective in patients with
more severe airﬂow limitation, which would be in keeping with
our ﬁndings of limited effectiveness.29 The IPD did not explore
subgroups based on recruitment setting.29
In conclusion, our ﬁndings fail to show a signiﬁcant beneﬁt of
supported self-management for primary care patients with COPD.
This has global importance for practice at a time when many
countries are moving to a case-ﬁnding approach based in primary
care to identify COPD patients earlier. From these ﬁndings it is
difﬁcult to recommend self-management support delivered in
primary or community settings for people managed in primary
care unless they are of higher intensity, which may not be feasible
in most usual primary care settings. In a resource limited
environment greater health gains are likely from targeting self-
management support to people who have had a recent hospital
admission for an exacerbation or identiﬁed from secondary care,
who are likely to be more limited by their symptoms. For patients
willing to attend a centre-based group programme, pulmonary
rehabilitation is an effective intervention.30,31 Self-management
interventions overall may need greater personalisation, as not all
people beneﬁt from the current approaches,32,33 and our evidence
suggests that these services should be delivered outside of usual
primary care. However, whilst self-management support as an
‘intervention’ in its current form is not effective in people with
mild/moderate COPD, people living with the condition may still
value support. Further research is recommended to identify the
support that will help people self-managing and adapting to life
with mild/moderate COPD to reduce the impact of this slowly
progressive condition.
METHODS
This was a protocol-driven systematic review registered on the PROSPERO
register of systematic reviews (CRD42016043958).7 No ethical approval was
required for this review as it used published data. The idea for the review
arose from a previous systematic review undertaken by the authors which
used a very broad deﬁnition of supported self-management interventions
in all settings to try to unpick the most effective components of self-
management interventions.7 This review is conﬁned to primary care
patients and uses a narrower deﬁnition of supported self-management.3
Eligibility criteria
To be included, studies had to be randomised controlled trials.
For inclusion we required at least 90% of the population to have COPD
(or results reported separately for COPD participants); trials had to have
recruited adult participants (aged 18 years or more) exclusively from
primary care. The criterion of at least 90% having COPD was pre-speciﬁed
and was to allow studies that were predominantly people with COPD to be
included.
To be eligible, the self-management intervention had to be delivered
entirely within primary care with no secondary or tertiary care attendance.
Self-management support was as deﬁned by Zwerink et al.3 to be an
iterative process (more than two contact moments over time), ideally
comprising formulation of goals and provision of feedback. Interventions
had to comprise at least two of the following elements (i) smoking
cessation; (ii) self-recognition of symptoms and self-treatment of exacer-
bations; (iii) an exercise or physical activity component; (iv) advice about
diet; (v) advice about medication; (vi) advice on coping with breath-
lessness. Interventions could be delivered verbally, by telephone or face-
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to-face, by written or audio-visual material (or a combination of the
aforementioned). Interventions that solely consisted of participant educa-
tion, those which included pulmonary rehabilitation (as in- or out-patient)
or those which were community-based but purely exercise were excluded.
Comparator arms could be no intervention, usual care, a control group, a
sham intervention or another self-management intervention.
The primary outcome measure was change in HRQoL as measured by a
validated score (including but not limited to the St George’s Respiratory
Questionnaire (SGRQ), Chronic Respiratory disease Questionnaire (CRQ) or
COPD Assessment Test (CAT)) as measured at last follow-up. Secondary
outcomes were health care utilisation, exacerbations, anxiety/depression,
exercise capacity, lung function, dyspnea and mortality.
Search strategy
The following databases were searched from date of inception, with no
language restrictions, for citations with potential relevance: MEDLINE,
MEDLINE in Process, EMBASE all via OVID, Cochrane Central Register of
Controlled Trials (CENTRAL), Cochrane Library (Wiley) CDSR, DARE, NHSEED
and HTA databases, Science Citation Index (ISI), PEDro, PsycINFO (OVID)
and Cochrane Airways specialised register. We include the search strategy
for one database (Supplementary methods: Search Strategy for MEDLINE).
This was then adapted appropriately for the remaining databases.
Initial searches were carried out as part of a previous systematic review
of self-management in any setting undertaken by Jolly et al.7 with an
updated search (with additional primary care focussed search terms) from
2012 to September 2017 to more efﬁciently identify additional publications
with recruitment from primary care. The reference lists of retrieved articles
and relevant reviews were searched manually. We have presented our
process of article selection in Fig. 1.
Study selection and data extraction
Articles identiﬁed in the search for the original systematic review were
selected as described in Jolly et al. 2016.7 Titles and abstracts identiﬁed in
the updated search to September 2017 were screened for potential
eligibility independently and in duplicate and full text articles then
reviewed independently by two reviewers for inclusion (KJ, HJSK, MS).
Discussion with a third reviewer resolved uncertainty regarding inclusion.
Data were extracted by a single researcher (SM) and checked indepen-
dently for accuracy by two reviewers (EB, MD). Reported mean difference
estimates and 95% conﬁdence intervals (CIs) calculated from an analysis of
covariance were preferred, otherwise, mean differences reported from an
analysis of change scores, an analysis of ﬁnal scores or change value were
used.
Authors were approached for additional outcome data where these
were not reported in a way that enabled inclusion in the meta-analyses.
Methodological quality assessment
The quality of the eligible studies was independently assessed by two
researchers (EB, MS) using the Cochrane Risk of Bias tool.34 Criteria
included randomisation, sequence generation, allocation concealment,
blinding (by outcome), completeness of outcome data, selective outcome
reporting and presence of other potential sources of bias (e.g. baseline
imbalance or incomplete baseline data). Studies were judged as having a
high risk of bias if one or more domains were assessed as being of high
risk.
Statistical analysis
Data were synthesised and reported narratively and in tables following
PRISMA guidelines. For data presented narratively we extracted mean
differences from baseline to ﬁnal follow-up (95% conﬁdence intervals). Due
to the heterogeneity of the interventions, a random effects model was
used for the meta-analyses.35 Meta-analysis was done in Stata versions 14
and 15. Statistical heterogeneity was assessed using the I2 statistic. All
continuous data were presented using a mean difference with 95%
conﬁdence intervals (95% CIs). Testing for funnel plot asymmetry was not
done due to there being <10 studies in each analysis.33
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